On Sept. 3, 2020, BioMedomics announced that the Therapeutic Goods Administration, a branch of the Department of Health in the Australian Government, has given BioMedomics authorization to sell and distribute our world-renown Sickle SCAN® rapid test in Australia! The have partnered with Helena Laboratories Australia to assist with distributing our product to customers.

Sickle SCAN^® is the world’s leading Sickle Cell Disease detection test, winning over competitor testing methods with:

• Fastest test result of 5 minutes
• Highest sensitivity/specificity (99%/99%)
• Differentiates trait from disease
• NO specialized training required
• NO electricity required

Sickle cell disease is an inherited group of blood disorders that causes normal, round red blood cells to turn into a stiff, C-like or banana shape, which blocks blood flow and breaks down early.